Hangzhou Genesis Biodetection & Biocontrol Ltd. (Abbreviated as “GENESIS”) is a joint venture of US and Japanese Companies of Diagnostic products with Chinese investors. The company was established in the Nov. of 2002, and registered in the Hangzhou Economic and Technology Development Zone. The company has initially invested >20 M Chinese RMB (about 4 M US $) on a piece of land >15000 square meter. With the aid of up-to-date technology and state-of-art equipment, and by leveraging of the experience and successful operation model of the investors accumulated abroad, GENESIS is aiming at providing its customers and end-users with top quality products and specialized services.